Realmind Biotech

Nanjing RealMind Biotech, founded in 2015, specializes in designing and manufacturing fully automated Chemiluminescence Immunoassay (CLIA) systems and reagents. Supported by a core technical team with extensive industry experience, over 30% of our workforce is dedicated to R&D. This commitment has enabled the launch of our A6i and MCL60 series – fully automated CLIA analyzers addressing critical unmet needs in emergency and clinical testing – backed by over 77 NMPA and 129 CE certified reagents. Building on this innovation foundation, we prioritize product quality as a CLIA solutions leader. Our flagship A6i and MCL60 systems deliver stable, accurate whole blood/capillary blood testing. The exceptional performance of the MCL60 directly facilitated our 2021 strategic partnership with Roche Diagnostics, now serving as its exclusive distributor in mainland China. Expanding beyond routine testing, we develop specialized assays alongside standard panels. Our portfolio covers routine areas including Thyroid, Fertility, Tumor Markers, Anemia and Glycometabolism; and specialized fields such as Cardiac/Inflammatory Markers, Reproductive Health, Women & Child Wellness, Bone Metabolism and Alzheimer’s Disease. Underpinning these efforts are our core principles: Market orientation, Customer centricity, Quality integrity, Innovation drive, Service commitment, and Collaborative partnerships – collectively advancing our mission “For Better Diagnosis”.